Investor Relations
Our mission is to revolutionize healthcare by defining, diagnosing, and restoring the functional health of the gut microbiome to prevent and treat chronic diseases, thereby improving health span and longevity.
Latest Investor Updates
Press Releases
Our Solutions
First in class evidence-based solutions to treat and prevent human disease by diagnosing and treating dysbiosis.
Generating data to develop microbiome-based interventions.